Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.
Kathryn E.  Wengel net worth and biography

Kathryn Wengel Biography and Net Worth

Kathy Wengel is Executive Vice President & Chief Global Supply Chain Officer for Johnson & Johnson, and a member of the Company’s Executive Committee. She has significant healthcare, operations and global business expertise – with more than three decades of experience in leadership positions with Johnson & Johnson.

In her current role, Kathy is responsible for all aspects of the development and implementation of the global Supply Chain for Johnson & Johnson, as well as its Quality & Compliance, Procurement, Environmental Health & Safety, Sustainability and Engineering & Property Services functions. A strong developer of globally diverse teams, Kathy leads an organization across three business segments: Pharmaceuticals, Medical Devices and Consumer Health.

Under Kathy’s leadership, Johnson & Johnson has been recognized by world-leading groups. The Company has been named #3 in both 2020 and 2021 on the Supply Chain Top 25 list by Gartner, Inc., the world’s leading research and advisory company. It also has the leading number of Lighthouse designations for its use of innovative technologies at production sites and other facilities – a designation granted by the World Economic Forum (WEF). Kathy is also one of the pioneers of the WEF’s Advanced Manufacturing Platform.

Since joining Johnson & Johnson in 1988, Kathy’s responsibilities have grown through a variety of strategic leadership and executive positions across the enterprise in multiple countries and in various roles within operations, quality, engineering, new product development, IT and other business functions. Kathy also served as the first Chief Quality Officer for Johnson & Johnson. During this time, she also co-led the design of the Company’s enterprise Supply Chain and Quality operating model. The effort brought together more than 20 disparate groups, all using core standards and operating principles, while delivering substantial value for the Company over the past decade.

Externally from Johnson & Johnson, Kathy serves as a member of the Board of Directors at LabCorp, a leading global life sciences company dedicated to using science to improve health and improve lives. She also serves as Chair of the Board of GS1 Global, a nonprofit that develops and maintains global supply chain standards. She is the Vice Chair of the Board of Directors at the National Association of Manufacturers in the U.S., and a member of the Board of Directors for the Manufacturing Institute. Kathy serves in several advisory capacities, including as member of the Executive Advisory Board for the Gartner Supply Chain practice and member of the Board of Advisors at AWESOME, a nonprofit working on the advancement of women in senior supply chain roles. Within Johnson & Johnson, Kathy is executive sponsor for the Women’s Leadership & Inclusion (WLI) initiative and the Women in Science, Technology, Engineering, Math, Manufacturing and Design (WiSTEM2D) program.

In 2019, Kathy was recognized by the Council of Supply Management Professionals (CSCMP) with its lifetime Distinguished Service Award, and she was elected to the Supply Chain Hall of Fame, the industry’s top individual supply chain honor. In 2015, Kathy received the National Association of Female Executives’ (NAFE) Women of Excellence Award and AWESOME’s Legendary Leadership Award in 2014.

Kathy holds a BSE degree in civil engineering and operations research from Princeton University.

What is Kathryn E. Wengel's net worth?

The estimated net worth of Kathryn E. Wengel is at least $10.69 million as of June 12th, 2023. Ms. Wengel owns 65,934 shares of Johnson & Johnson stock worth more than $10,689,220 as of March 3rd. This net worth estimate does not reflect any other assets that Ms. Wengel may own. Learn More about Kathryn E. Wengel's net worth.

How do I contact Kathryn E. Wengel?

The corporate mailing address for Ms. Wengel and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400 and via email at [email protected]. Learn More on Kathryn E. Wengel's contact information.

Has Kathryn E. Wengel been buying or selling shares of Johnson & Johnson?

Kathryn E. Wengel has not been actively trading shares of Johnson & Johnson during the last ninety days. Most recently, Kathryn E. Wengel sold 12,465 shares of the business's stock in a transaction on Monday, June 12th. The shares were sold at an average price of $160.00, for a transaction totalling $1,994,400.00. Following the completion of the sale, the executive vice president now directly owns 65,934 shares of the company's stock, valued at $10,549,440. Learn More on Kathryn E. Wengel's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), James Swanson (Insider), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 5 times. They sold a total of 107,622 shares worth more than $17,375,074.11. The most recent insider tranaction occured on February, 9th when EVP Jennifer L Taubert sold 59,397 shares worth more than $9,281,969.19. Insiders at Johnson & Johnson own 0.2% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 2/9/2024.

Kathryn E. Wengel Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/12/2023Sell12,465$160.00$1,994,400.0065,934View SEC Filing Icon  
11/9/2022Sell16,410$173.42$2,845,822.2071,311View SEC Filing Icon  
6/10/2022Sell40,000$173.00$6,920,000.0071,311View SEC Filing Icon  
9/2/2020Sell16,115$153.52$2,473,974.8066,658View SEC Filing Icon  
12/12/2019Sell2,017$141.07$284,538.1951,736View SEC Filing Icon  
See Full Table

Kathryn E. Wengel Buying and Selling Activity at Johnson & Johnson

This chart shows Kathryn E Wengel's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Read More

Today's Range

Now: $162.12
Low: $161.09
High: $162.57

50 Day Range

MA: $159.19
Low: $155.46
High: $162.50

2 Week Range

Now: $162.12
Low: $144.95
High: $175.97

Volume

5,670,135 shs

Average Volume

7,513,903 shs

Market Capitalization

$390.51 billion

P/E Ratio

11.74

Dividend Yield

2.94%

Beta

0.53
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Full details and steps to take here.